CDC mpox update

The emergence of mpox resistant tecovirimat has sparked significant concern among health officials, especially in light of the increasing number of cases linked to a tecovirimat-resistant monkeypox virus (MPXV) in the United States.With the monkeypox outbreak 2024 presenting new challenges, the ability of the virus to resist current treatment options underscores the urgent need for effective solutions.